Abstract

Abstract Hyaluronic acid (HA) is a component of the extracellular matrix with important potential for biotechnological and pharmaceutical applications. However, the immunological effects of HA are strongly molecular weight-dependent; therefore, production of HA for therapeutic purposes requires control over the molecular weight of the product, as well as mild reaction conditions and elimination of bioactive impurities. Here, we produced and characterised biocompatible magnetic macroporous bead cellulose (MBC) functionalised with Streptococcus pneumoniae hyaluronan lyase (SpnHL) that are compatible with these requirements and optimised their reaction and storage conditions. Immobilisation of SpnHL on MBC via reductive amination or MBC with fixed iminodiacetic acid (MBC-IDA) via a His8-tag had minimal impact on its catalytic activity. The MBC-IDA-SpnHL carrier showed excellent operational and storage stability, and both carriers enabled reproducible time-controlled fragmentation of highly viscous HMW HA solutions, yielding HA fragments of appropriate molecular weight. Thus, these carriers are suitable for numerous industrial and biotechnological applications.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.